期刊文献+

大内皮素-1与肥厚型梗阻性心肌病患者心脏重构的相关性分析 被引量:8

Correlation Study Between Blood Level of Big Endothelin-1 and Cardiac Remodeling in Patients With Hypertrophic Obstructive Cardiomyopathy
下载PDF
导出
摘要 目的:探讨血浆大内皮素-1(Big ET-1)水平与肥厚型梗阻性心肌病(HOCM)患者心脏重构的相关性。方法:入选自2015-01至2016-05于我院住院治疗的HOCM患者167例,测定血浆Big ET-1、N末端B型利钠肽原(NT-pro BNP)水平等指标,完善心电图、动态心电图、超声心动图(UCG)及心脏磁共振成像(CMR)检查,进行相关统计学分析。结果:在167例HOCM患者中,相关性分析及多元线性回归发现Ln Big ET-1与Ln NT-pro BNP(r=0.35,P=0.000)、左心房前后径(r=0.169,P=0.019)及心率(r=0.141,P=0.037)呈正相关,与血红蛋白(r=-0.173,P=0.013)及室间隔厚度/左心室后壁厚度比值(r=-0.165,P=0.017)呈负相关。基于Big ET-1与左心房前后径呈正相关的发现,将研究对象分为左心房正常组74例及左心房增大组93例。与左心房正常组比,左心房增大组患者血浆Big ET-1水平显著增高(P=0.001);UCG测量的左心室舒张末期内径较大(P=0.024),室间隔较厚(P=0.003),左心室射血分数偏低(P=0.001);CMR测量的左心室舒张末期容积(P=0.002)及室间隔厚度(P=0.002)较大;伴发心房颤动的比率增加(P=0.004);存在二尖瓣中-大量反流(P=0.011)及纽约心脏协会(NYHA)心功能Ⅲ或Ⅳ级(P=0.022)的患者增多。结论:在HOCM患者中,Ln Big ET-1与Ln NT-pro BNP、左心房内径呈正相关。左心房增大的HOCM患者血浆Big ET-1水平显著升高,心脏结构重构更明显,伴发心房颤动的比率增加。Big ET-1可能在HOCM患者的心脏重构中发挥作用。 Objective:To explore the relationship between big endothelin-1(big ET-1) and cardiac remodeling in patients with hypertrophic obstructive cardiomyopathy(HOCM).Methods:A total of 167 consecutive HOCM patients admitted in our hospital from 2015-01 to 2016-05 were enrolled.Blood levels of big ET-1 and NT-pro BNP were measured;electrocardiogram(ECG),dynamic ECG,echocardiography(UCG) and cardiovascular magnetic resonance(CMR) were examined for relevant statistical analysis.Results:In all 167 HOCM patients,blood level of Big ET-1 was positively related to NT pro-BNP(r=0.35,P=0.000),left atrial(LA) diameter(r=0.169,P=0.019) and heart rate(r=0.141,P=0.037);negatively related to hemoglobin(r=-0.173,P=0.013) and the ratio of interventricular septum(IVS)/posterior wall of left ventricle(r=-0.165,P=0.017).Based on the finding of positive correlation between Big ET-1 and LA diameter,the patients were divided into 2 groups:Normal LA group,n=74 and Enlarged LA group,n=93.Compared with Normal LA group,Enlarged LA group had the higher blood level of Big ET-1(P=0.001);increased left ventricular end-diastolic diameter(LVEDD)(P=0.024),thicker IVS(P=0.003),lower LVEF(P=0.001);enlarged LVED volume(P=0.002) and IVS(P=0.002);elevated ratio of atrial fibrillation(AF);more patients withmoderate to severe mitral regurgitation(MR) and NYHA functional class III/IV.Conclusion:Blood level of Big ET-1 was positively related to NT pro-BNP and LA diameter in HOCM patients;the patients with enlarged LA had increased Big ET-1,more obvious cardiac remodeling and the higher incidence of AF occurrence which implied that Big ET-1 might play the role in cardiac remodeling in HOCM patients.
出处 《中国循环杂志》 CSCD 北大核心 2017年第1期58-62,共5页 Chinese Circulation Journal
基金 基金项目:首都临床特色应用研究(Z111107058811005)
关键词 心肌病 肥厚性 大内皮素-1 心脏重构 Cardiomyopathy hypertrophic Big endothelin-1 Cardiac remodeling
  • 相关文献

参考文献2

二级参考文献23

  • 1曾治宇,王方正,谭琛,张澍,浦介麟.心房颤动与C反应蛋白[J].中国循环杂志,2005,20(3):197-199. 被引量:6
  • 2Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. Circulation, 1996, 93: 1262-1277.
  • 3Aviles R J, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation, 2003, 108: 3006-3010.
  • 4Kourliouws A, Savelieva I, Kiotsekoglou A, et al. Current concepts in the pathogenesis of atrial fibrillation. Am Heart J, 2009, 157: 243- 252.
  • 5Watts SW, Thakali K, Smark C, et al. Big ET-I processing into vasoactive peptides in arteries and veins. Vascul Pharmacol, 2007, 47: 302-312.
  • 6Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 1997, 96: 1180-1184.
  • 7Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile periearditis model. Cardiovasc Res, 2004, 62:105-111.
  • 8Bruins P, te Vehhuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation, 1997, 96: 3542-3548.
  • 9Malouf JF, Kanagala R, A1 AF, et al. High sensitivity C-reactive protein: A novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coil Cardiol, 2005, 46: 1284-1287.
  • 10Lin YJ, Tsao HM, Chang SL, et al. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. Am J Cardiol, 2010, 105: 495-501.

共引文献24

同被引文献71

引证文献8

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部